| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $200.97B | +22.2% |
| Cost of Revenue | $36.17B | +19.9% |
| R&D Expense | $57.37B | +30.8% |
| SG&A Expense | $12.15B | +24.8% |
| Operating Income | $83.28B | +20.0% |
| Interest Expense | $1.09B | +59.6% |
| Pre-tax Income | $85.93B | +21.6% |
| Income Tax | $25.47B | +206.8% |
| Net Income | $60.46B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.87B | -18.3% |
| Short-term Investments | $45.72B | +34.8% |
| Accounts Receivable | $19.77B | +16.3% |
| Current Assets | $108.72B | +8.7% |
| Total Assets | $366.02B | +32.6% |
| Current Liabilities | $41.84B | +24.5% |
| Long-term Debt | $58.74B | +103.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $115.80B | +26.8% |
| Capital Expenditures | $69.69B | +87.1% |
| Investing Cash Flow | -$102.00B | -116.3% |
| Financing Cash Flow | -$20.37B | +50.1% |
| Free Cash Flow | $46.11B | -14.7% |
| -3.1% |
| EPS (Basic) | $23.98 | -2.6% |
| EPS (Diluted) | $23.49 | -1.6% |
| Total Liabilities |
| $148.78B |
| +59.3% |
| Stockholders' Equity | $217.24B | +18.9% |